Cell and Gene Therapy Tools and Reagents: Global Markets

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $5,500	139 Pages	BCC Research	October, 2022	WA17488005

Attention: There is an updated edition available for this report.

Best Price Guarantee
Price	from $5,500
Length	139 Pages
Publisher	BCC Research
Published Date	October, 2022
SKU	WA17488005

Cell and Gene Therapy Tools and Reagents: Global Markets

Report Scope:

The scope of this study encompasses an investigation of cell and gene therapy tools: GMP proteins, media, cell separation and activation reagents, viral and non-viral, cytokine release syndrome monitoring products, GMP antibodies, leukapheresis instrumentation, immunoassays (multiplex and singleplex) and bioreactors. BCC Research analyzes each tool type, determines its current market status, examines its impact on future markets and presents forecasts of growth over the next six years. The current report provides detailed analysis of the market's drivers, challenges and opportunities. The report also covers market projections to 2027 and market share for key market players. The report includes the company profiles of key players with detailed information about business segments, financials, product portfolios and recent developments. The report provides impact analysis of the COVID-19 pandemic on this market.
Report Includes:
105 total tables

An updated overview of the global market for immunoassay-based cell and gene therapy tools and reagents

Analyses of the global market trends, with historic market revenue for 2019-2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027

Highlights of the market potential for the cell and gene therapy tools and reagents in the life sciences industry, growth driving factors, and areas of focus to forecast this market into various segments and sub-segments

Estimation of actual market size and revenue forecast for cell and gene therapy tools and reagents in USD million terms, and corresponding market share analysis based on product, application/disease area, end-user, and region

In-depth information (facts and figures) concerning major market dynamics (DROs), product innovations, clinical trials, and various government regulations affecting the market outlook for cell and gene therapy tools and reagents

Review of prevalence of infectious disease, metabolic disorders and chronic ailments; along with the recent technological advancements, competitive environment, and the industry value chain analysis

Coverage of the technological, economic, and business considerations of the prevailing cell and gene therapy tools market, and its vendor landscape

Patent review and new developments, R&D efforts, industrial changes with emphasis on recent investments, and current state of the immunoassay technology

Identification of the companies best positioned to meet the demand for cell and gene therapy in life sciences applications owing to their proprietary technologies, novel product launches, key mergers and acquisition deals, and other strategic advantages

Descriptive company profiles of the market leading players, including Abcam, Akron Biotech, Adverum Biotechnologies and Avrobio.

Companies Mentioned

ABCAM
ADVERUM BIOTECHNOLOGIES
AKRON BIOTECH
ATHERSYS INC.
AVROBIO
BIO-RAD LABORATORIES
BIO-TECHNE
CELLGENIX
CYTIVA LIFE SCIENCES
Fujifilm Irvine Scientific
LUMINEX CORP.
MERCK KGAA
MESOBLAST LTD.
MILTENYI BIOTEC
ORGANICELL
PROTEINTECH GROUP INC.
SARTORIUS
SINO BIOLOGICAL INC.
STEMCELL TECHNOLOGIES
THERMO FISHER SCIENTIFIC

Chapter 1 Introduction: 1.1 Study Goals and Objectives; 1.2 Reasons for Doing This Study; 1.3 Scope of Report; 1.4 What’s New in This Update?; 1.5 Information Sources; 1.6 Methodology; 1.7 Geographic Breakdown; 1.8 Analyst’s Credentials; 1.9 BCC Custom Research; 1.10 Related BCC Research Reports
Chapter 2 Summary and Highlights
Chapter 3 Market and Technology Background: 3.1 Overview: Cell and Gene Therapy; 3.1.1 Cell Therapy; 3.1.2 Gene Therapy; 3.2 Types of Cell and Gene Therapy; 3.2.1 Gene Therapy; 3.2.2 Cell Therapy; 3.2.3 Evolution and Expansion of Therapies; 3.2.4 Common Equipment Used
Chapter 4 Market Dynamics: 4.1 Factors Affecting the Market; 4.2 Market Drivers; 4.2.1 Increasing Investment in CGT R&D; 4.2.2 Capacity Expansions for Clinical and Commercial Manufacturing; 4.2.3 Increasing Incidence of Chronic Diseases; 4.2.4 Increasing Strategic Collaborations and Acquisitions; 4.2.5 Market Restraints; 4.2.6 Complex Manufacturing and Supply Chain; 4.2.7 Lack of Skilled Workforce; 4.2.8 Market Opportunities; 4.3 Impact of COVID-19
Chapter 5 Market Breakdown, by Application: 5.1 Cell and Gene Therapy Tools and Reagents Market; 5.2 Cancer; 5.3 Rare Diseases; 5.4 Other Diseases
Chapter 6 Market Breakdown, by End User: 6.1 Biotechnology and Pharmaceutical Companies; 6.2 Academic and Research Institutes; 6.3 Clinical Laboratories/Hospitals; 6.4 GMP Proteins
Chapter 7 Market Breakdown, by Type: 7.1 GMP Proteins; 7.1.1 GMP Proteins by Application; 7.1.2 GMP Proteins, by End User; 7.2 Media; 7.2.1 Media by Application; 7.2.2 Media by End User; 7.3 Cell Separation; 7.3.1 Cell-Separation by Application; 7.3.2 Cell Separation by End User; 7.4 Cell Expansion; 7.4.1 Cell Expansion by Application; 7.4.2 Cell Expansion by End User; 7.5 Vectors; 7.5.1 Vectors by Application; 7.5.2 Vectors, by End User; 7.6 GMP Small Molecules; 7.6.1GMP Small Molecules by Application; 7.6.2 GMP Small Molecules, by End User; 7.7 GMP Antibodies; 7.7.1 GMP Antibodies, by Application; 7.7.2 GMP Antibodies, by End User; 7.8 Leukapheresis; 7.8.1 Leukapheresis, by Application; 7.8.2 Leukapheresis by End User; 7.9 Cryopreservation; 7.9.1 Cryopreservation, by Application; 7.9.2 Cryopreservation by End User; 7.10 Bioreactors; 7.10.1 Bioreactors, by Application; 7.10.2 Bioreactors, by End User; 7.11 Immunoassays and Multiplex Immunoassays; 7.11.1 Immunoassays, by Application; 7.11.2 Immunoassays, by End User; 7.11.3 Multiplex Immunoassays, by Application; 7.11.4 Multiplex Immunoassays, by End User; 7.12 Cytokine Release Testing; 7.12.1 Cytokine Release Testing, by Application; 7.12.2 Cytokine Release Testing by End User
Chapter 8 Market Breakdown by Region: 8.1 North America; 8.2 Europe; 8.3 Asia-Pacific; 8.4 Rest of the World
Chapter 9 Government Regulations: 9.1 Scope of Regulations on Gene Therapy; 9.1.1 Viral and Non-Viral Vectors; 9.1.2 Media; 9.1.3 GMP Proteins and Antibodies; 9.1.4 Cell Therapy; 9.1.5 Leukapheresis; 9.1.6 Cell Therapy, Gene Therapy and the EMA
Chapter 10 Patent Review/New Developments: 10.1 Cell and Gene Therapy R&D; 10.1.1 Academia; 10.2 Technology; 10.2.1 Key Patents
Chapter 11 Competitive Landscape: 11.1 Mergers and Acquisitions; 11.1.1 Strategic Initiatives; 11.2 Competitive Analysis
Chapter 12 Company Profiles: ABCAM; AKRON BIOTECH; ADVERUM BIOTECHNOLOGIES; ATHERSYS INC.; AVROBIO; BIO-RAD LABORATORIES; BIO-TECHNE; CELLGENIX; CYTIVA LIFE SCIENCES; FUJIFILM IRVINE SCIENTIFIC; LUMINEX CORP.; MESOBLAST LTD.; MERCK KGAA; MILTENYI BIOTEC; ORGANICELL; PROTEINTECH GROUP INC.; SARTORIUS; SINO BIOLOGICAL INC.; STEMCELL TECHNOLOGIES; THERMO FISHER SCIENTIFIC